COLLEGIUM PHARMACEUTICAL ANNOUNCES THE ACHIEVEMENT OF DEVELOPMENT MILESTONE UNDER THE AGREEMENT WITH CYPRESS BIOSCIENCE

Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, today announced the achievement of a development milestone that is a subject of the Reformulation and New Product Agreement with Cypress Bioscience, Inc.

Genetic Engineering News (http://www.genengnews.com/news/bnitem.aspx?name=2235391)